Susquehanna International Group, LLP Eli Lilly & CO Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

A detailed history of Susquehanna International Group, LLP transactions in Eli Lilly & CO stock. As of the latest transaction made, Susquehanna International Group, LLP holds 482,252 shares of LLY stock, worth $421 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

482,252

Previous 432,279 11.56%

Holding current value

$421 Million

Previous $383 Million 2.79%

% of portfolio

0.06%

Previous 0.07%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$727.2 - $932.06 $36.3 Million - $46.6 Million	49,973 Added 11.56%	482,252 $372 Million
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $72.1 Million - $89.7 Million	93,399 Added 27.56%	432,279 $383 Million
Q2 2024 Aug 15, 2024	BUY	$724.87 - $909.04 $83.8 Million - $105 Million	115,617 Added 51.79%	338,880 $307 Million
Q1 2024 May 07, 2024	SELL	$592.2 - $792.28 $64.6 Million - $86.4 Million	-109,040 Reduced 32.81%	223,263 $174 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $3.91 Million - $4.61 Million	-7,451 Reduced 2.19%	332,303 $194 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $29.1 Million - $40.2 Million	-67,026 Reduced 16.48%	339,754 $182 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $13.3 Million - $17.8 Million	-37,992 Reduced 8.54%	406,780 $191 Million
Q1 2023 May 16, 2023	BUY	$310.63 - $364.82 $46.8 Million - $55 Million	150,633 Added 51.21%	444,772 $153 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $78.6 Million - $91.6 Million	244,419 Added 491.59%	294,139 $108 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $56 Million - $63.9 Million	-188,991 Reduced 79.17%	49,720 $16.1 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $13 Million - $15.3 Million	46,627 Added 24.27%	238,711 $77.4 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $1.19 Million - $1.48 Million	-5,069 Reduced 2.57%	192,084 $55 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $51 Million - $63.2 Million	-226,629 Reduced 53.48%	197,153 $54.5 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $23.7 Million - $29.2 Million	107,171 Added 33.85%	423,782 $97.9 Million
Q2 2021 Aug 11, 2021	SELL	$180.55 - $233.54 $6 Million - $7.77 Million	-33,251 Reduced 9.5%	316,611 $72.7 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $37.6 Million - $48.7 Million	228,755 Added 188.89%	349,862 $65.4 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $4.97 Million - $6.58 Million	-38,103 Reduced 23.93%	121,107 $20.4 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $5.19 Million - $6.01 Million	35,516 Added 28.71%	159,210 $23.6 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $11 Million - $13.2 Million	80,442 Added 185.98%	123,694 $20.3 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $23.4 Million - $29 Million	-196,684 Reduced 81.97%	43,252 $6 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $22.7 Million - $28.1 Million	212,073 Added 761.13%	239,936 $31.5 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $1.68 Million - $1.83 Million	15,744 Added 129.91%	27,863 $3.12 Million
Q2 2019 Aug 16, 2019	BUY	$110.79 - $129.32 $698,420 - $815,233	6,304 Added 108.41%	12,119 $1.34 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $289,605 - $338,042	2,614 Added 81.66%	5,815 $644,000
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $1.23 Million - $1.45 Million	-11,056 Reduced 77.55%	3,201 $415,000
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $80,469 - $92,353	1,063 Added 8.06%	14,257 $1.22 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $223,075 - $263,325	-3,006 Reduced 18.56%	13,194 $1.02 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $1.33 Million - $1.42 Million	16,200	16,200 $1.37 Million

Others Institutions Holding LLY

# of Institutions

4,261

Shares Held

756M

Call Options Held

10.2M

Put Options Held

11.4M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $830B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Eli Lilly & CO Transaction History